The Korean Journal of Gastroenterology :eISSN 2233-6869 / pISSN 1598-9992


Table. 1.

Endpoints for Autoimmune Hepatitis Treatment as Proposed after a Consensus Process by the International Autoimmune Hepatitis Working Group

Endpoint Definition
Complete biochemical response Normalization of serum transaminases and IgG below the ULN within 6 months of treatment
Insufficient response Lack of complete biochemical response. Should be determined no later than 6 months after initiation of treatment
Non-response <50% decrease of serum transaminases within 4 weeks after initiation of treatment
Remission Hepatitis activity index <4
Intolerance to treatment Any adverse event possibly related to treatment as assessed by the treating physician leading to potential discontinuation of the drug

IgG, immunoglobulin G; ULN, upper limit of normal range.

Korean J Gastroenterol 2023;81:72~85
© Korean J Gastroenterol